Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of midodrine with L-carnitine in the treatment of intradialytic hypotension
IRCT20231223060507N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midodrine and levocarnitine in end-stage kidney disease (ESKD) and intradialytic hypotension (IDH) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
midodrinelevocarnitine
03
Conditions
end-stage kidney disease (ESKD)intradialytic hypotension (IDH)
Beyond the preview
Go deeper on IRCT20231223060507N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231223060507N1.